Skip to content

    Lung Cancer Health Center

    Font Size
    A
    A
    A

    Lung Cancer Drug Iressa Fails Test.

    Recently Approved Drug Fails to Save Lives in Clinical Trial

    WebMD Health News

    Dec. 21, 2004 - A lung cancer drug recently approved under the FDA's accelerated approval process has failed to provide any benefits for those taking it in a major clinical trial.

    The results of the trial, released last week, show that the lung cancer patients who took the drug Iressa did not live any longer than those who took a placebo.

    FDA officials say lung cancer patients currently taking Iressa should consult with their doctors as soon as possible but should not change their treatment without first talking to their doctor.

    Other chemotherapy drugs for lung cancer include Taxotere and Tarceva, which have been shown to extend the life of people with non-small-cell lung cancer whose cancer has progressed while being treated with other drugs.

    Iressa was approved in May 2003 to treat people with non-small-cell lung cancer who had failed two or more courses of chemotherapy. Non-small-cell lung cancer is the most common form of lung cancer and accounts for about 80% of all cases.

    The FDA's accelerated approval process allows the agency to approve a drug for marketing if it's deemed reasonably likely to benefit people taking the drug.

    FDA officials say Iressa was approved because data from initial clinical trials showed that it caused tumors to shrink in 10% of lung cancer patients, which was thought to predict a survival benefit.

    Another provision of the accelerated approval program is that the drug's manufacturer must further study the drug to verify the expected benefit.

    In this case, a clinical trial started after the approval of Iressa looked at 1,700 lung cancer patients. The study showed that the drug did not prolong survival. Iressa's maker, AstraZeneca, is a WebMD sponsor.

    Under the program, the FDA may remove from the market a drug that fails to show a benefit. Officials say a decision will be made regarding Iressa after they have evaluated the recent study results.

    Today on WebMD

    Xray analysis
    Do you know the myths from the facts?
    chest x-ray
    Get to know them.
     
    woman taking pills
    Tips to managing them.
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    Lung Cancer Risks Myths and Facts
    SLIDESHOW
    Woman getting ct scan
    Article
     
    Improving Lung Cancer Survival Targeted Therapy
    VIDEO
    cancer fighting foods
    Article
     
    Lung Cancer Surprising Differences Between Sexes
    VIDEO
    Pets Improve Your Health
    SLIDESHOW
     
    Vitamin D
    SLIDESHOW
    Lung Cancer Surgery Options
    VIDEO